Mangoceuticals enters advisory consulting agreement and receives $120K from warrant exercise

MANGOCEUTICALS, INC.

Issued 200,000 restricted shares to 6330 Investment & Consulting for 12-month strategic advisory services.
Received $120,000 aggregate exercise price for 80,000 shares from a warrant holder at $1.50 per share.
Consultant will provide introductions for strategic partners and M&A opportunities; estimated 10 hours/week.
Shares issued under Section 4(a)(2) exemption; no public offering or underwriting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.